Literature DB >> 11468237

Excitatory amino acids in cerebrospinal fluid of patients with acute head injuries.

H Zhang1, X Zhang, T Zhang, L Chen.   

Abstract

BACKGROUND: The excitatory amino acids (EAAs) glutamate (Glu) and aspartate (Asp) play a role in the pathogenesis of postischemic and posttraumatic brain insult. The changes of EAAs in cerebrospinal fluid (CSF) of patients with traumatic brain injury are incompletely understood.
METHODS: We used reversed-phase HPLC with precolumn derivatization with o-phthalaldehyde and fluorescence detection to measure Glu and Asp in CSF of 42 patients with acute head injury and 9 control adults without neurologic diseases. We assessed the Glasgow Coma Scale (GCS) on admission, the main lesion patterns on computed tomography (CT) scan within 24 h post trauma, and the Glasgow Outcome Scale (GOS) 3 months post injury.
RESULTS: The mean concentrations of Glu and Asp in CSF in the brain-injured group were significantly higher than those of the control group (Glu, P <0.001; Asp, P <0.05). In patients admitted within 24 h after severe injury (n = 13), peak Glu values appeared within 48 h in 11 patients (85%), and the mean value remained higher than control values at day 7 (P <0.02). The concentrations of EAAs were higher in patients with severe injuries (GCS < or =8) than in those with milder injuries (Glu, P <0.001; Asp, P <0.05). GCS and peak EAAs correlated negatively (Glu, rs = -0.5706, P <0.001; Asp, rs = -0.5503, P <0.001). The patients with focal brain contusion on initial CT scan (n = 8) had a significantly lower peak Glu value than the patients with other patterns (n = 8-15; P <0.02 to 0.001). The peak value of EAAs in the poor-outcome group (including severe disability, vegetative state, and death) was significantly higher than in the good-outcome group (good recovery and moderate disability; Glu, P <0.001; Asp, P <0.01); GOS was closely correlated to the EAA values (Glu, rs = 0.5737, P <0.001; Asp, rs = 0.5470, P <0.001).
CONCLUSIONS: The EAA concentrations in CSF increase after acute head injury and remain higher for at least 1 week post injury in severely injured patients. The more severe the trauma, the more obvious the excitotoxicity induced by EAAs and the worse the outcome.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11468237

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  23 in total

Review 1.  Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

Authors:  Jennifer L McGuire; Laura B Ngwenya; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

Review 2.  Application of advanced neuroimaging modalities in pediatric traumatic brain injury.

Authors:  Stephen Ashwal; Karen A Tong; Nirmalya Ghosh; Brenda Bartnik-Olson; Barbara A Holshouser
Journal:  J Child Neurol       Date:  2014-06-22       Impact factor: 1.987

3.  The effect of pyruvate on the development and progression of post-stroke depression: A new therapeutic approach.

Authors:  Dmitry Frank; Ruslan Kuts; Philip Tsenter; Benjamin F Gruenbaum; Yulia Grinshpun; Vladislav Zvenigorodsky; Ilan Shelef; Dmitry Natanel; Evgeny Brotfain; Alexander Zlotnik; Matthew Boyko
Journal:  Neuropharmacology       Date:  2019-05-31       Impact factor: 5.250

4.  The activation of β2-adrenergic receptors in naïve rats causes a reduction of blood glutamate levels: relevance to stress and neuroprotection.

Authors:  Alexander Zlotnik; Yael Klin; Benjamin F Gruenbaum; Shaun E Gruenbaum; Sharon Ohayon; Mathew Boyko; Eyal Sheiner; Barak Aricha-Tamir; Yoram Shapira; Vivian I Teichberg
Journal:  Neurochem Res       Date:  2011-01-05       Impact factor: 3.996

5.  Glucagon protects against impaired NMDA-mediated cerebrovasodilation and cerebral autoregulation during hypotension after brain injury by activating cAMP protein kinase A and inhibiting upregulation of tPA.

Authors:  William M Armstead; J Willis Kiessling; Douglas B Cines; Abd Al-Roof Higazi
Journal:  J Neurotrauma       Date:  2011-03-04       Impact factor: 5.269

6.  The effect of blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome in a rat model of subarachnoid hemorrhage.

Authors:  Matthew Boyko; Israel Melamed; Benjamin Fredrick Gruenbaum; Shaun Evan Gruenbaum; Sharon Ohayon; Akiva Leibowitz; Evgeny Brotfain; Yoram Shapira; Alexander Zlotnik
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

7.  Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naïve rats.

Authors:  Matthew Boyko; David Stepensky; Benjamin F Gruenbaum; Shaun E Gruenbaum; Israel Melamed; Sharon Ohayon; Michael Glazer; Yoram Shapira; Alexander Zlotnik
Journal:  Neurochem Res       Date:  2012-07-31       Impact factor: 3.996

Review 8.  Excitatory amino acid inhibitors for traumatic brain injury.

Authors:  C Willis; S Lybrand; N Bellamy
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 9.  A review of heat shock protein induction following cerebellar injury.

Authors:  Laura P R Reynolds; Gary V Allen
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

Review 10.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.